NCT02784171 2024-12-10
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
Phase 2/3 Completed
Clinical Trials
37 trialsNCT00357747 2023-08-04
AEG35156 and Docetaxel in Treating Patients With Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00372736 2023-08-04
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00504296 2023-08-04
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT01486368 2023-08-04
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
Phase 2 Completed
NCT00101283 2023-07-03
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00673257 2020-04-14
Pharmacokinetics of Daunorubicin in Young Patients With Cancer
Children's Oncology Group
Phase NA Completed
NCT00003891 2020-04-09
Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00003890 2020-04-06
MG98 in Treating Patients With Advanced Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00003684 2020-04-03
Theophylline in Treating Cancer Patients With Shortness of Breath
Canadian Cancer Trials Group
Phase 3 Completed
NCT00690469 2019-10-08
Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers
Children's Oncology Group
Completed
NCT00458913 2018-07-12
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT02164838 2018-01-29
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT00897442 2016-10-28
Collecting Tumor Samples From Patients With Gynecological Tumors
GOG Foundation
Completed
NCT02764398 2016-05-11
Cardio-respiratory Events During Ophthalmic Artery Chemotherapy for Retinoblastoma Under a Deep Anesthesia
Fondation Ophtalmologique Adolphe de Rothschild
Completed
NCT01798654 2016-02-19
EUS-FNA for Patients With Antithrombotic Agents
Hokkaido Pancreatobiliary Endoscopic Intervention Study Group
Completed
NCT00513877 2014-12-31
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Cancer Trials Ireland
Phase 2 Completed
NCT00003597 2014-07-24
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT00006095 2014-02-21
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
Children's Oncology Group
Phase 1 Completed
NCT00006463 2014-02-21
Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT00070473 2014-02-20
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT01048892 2014-01-30
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Children's Oncology Group
Phase 1 Completed
NCT00387504 2013-09-12
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
California Cancer Consortium
Phase 1 Completed
NCT00433394 2013-06-27
Registration and Informed Consent Study for the Childhood Cancer Research Network
Children's Oncology Group
Phase NA Completed
NCT00003723 2012-10-08
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
SWOG Cancer Research Network
Phase 2 Completed
NCT00004886 2012-09-24
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00045019 2012-08-27
Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
European Organisation for Research and Treatment of Cancer - EORTC
Completed
NCT00006354 2012-07-24
Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00004920 2012-07-18
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00005061 2012-07-18
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00006477 2012-07-18
Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00227630 2012-07-18
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00003976 2012-07-11
E7070 in Treating Patients With Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00003981 2012-07-11
E7070 in Treating Patients With Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00002904 2012-07-02
Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00003028 2012-07-02
MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Completed
NCT00006246 2009-10-07
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
Pediatric Brain Tumor Consortium
Phase 1 Completed